Cerebral Therapeutics raises $3m for epilepsy drug-device therapy

Cerebral Therapeutics closed a $3 million Series A financing round this week to support the development of its drug-device therapy designed for patients with refractory epilepsy.
The Aurora, Co.-based company’s product uses an implanted, refillable catheter system to deliver a continuous, intracerebroventricular dose of an anti-epileptic drug – valproic acid.
Get the full story at our sister site, Drug Delivery Business News.
The post Cerebral Therapeutics raises $3m for epilepsy drug-device therapy appeared first on MassDevice.

Source: Mass Device - June 21, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Funding Roundup Neurological Pharmaceuticals Cerebral Therapeutics Source Type: news